MONA, a technological spin-off of KU Leuven and research institute VITO, has developed artificial intelligence that can detect the first signs of blindness. Starting this year, the technology will be available to hospitals and ophthalmologists.

The technology is currently focused on diabetic retinopathy, a condition caused by diabetes that causes the blood vessels of the retina to become damaged. In the long term, the disease can lead to blindness. An annual eye examination is necessary to detect the condition in time, but not all patients get tested enough.

"Our technology allows us to detect the risk of diabetic retinopathy with a single eye scan," says Olivier Ménage, CEO of MONA. "We can also detect the disease from a very early stage, and the technology is cost-effective. The accessibility for screenings is increased: that is why it is such an important innovation."

Currently, the research team is improving the technology so that it can eventually detect glaucoma as well. For this, it could receive the European quality label CE in 2023, which it already has for detecting diabetic retinopathy.

In the future, numerous other diseases could even be detected by unleashing artificial intelligence on eye scans, Ménage makes the case. These include Alzheimer's disease and cardiovascular conditions, where links can be seen with the state of a person's eyes.

Related articles

Smarth Health: when technology and ethics collide

Smarth Health: when technology and ethics collide

Who will oppose an ever increasing life expectancy? A rhetorical question, but nevertheless there is a flip side to unrelenting medical progress. The outlines of which are already clear, especially in the ethical realm. Given the technology for monitoring your body, exercise and food intake, to what extent is health an individual responsibility, thus redefining medical solidarity?

Become one of our partners

Do you want to join one of the biggest innovation communities of Europe and share your innovative brand with the world?

info@livingtomorrow.com
+32 2 263 01 33

Indringingsweg 1
1800 Vilvoorde
Belgium